Human Phenotype Ontology 
Grandparent Node:
expand
Abnormality of the skin (HP:0000951)help
Parent Node:
expand
Abnormality of skin morphology (HP:0011121)help
..Starting node
..expand
Dermal translucency (HP:0010648)help
Term ID: 10648
Name: Dermal translucency
Synonym: Translucent skin
Definition: An abnormally increased ability of the skin to permit light to pass through (translucency) such that subcutaneous structures such as veins display an increased degree of visibility.
Comments:
Reference: HP:0010648
Genes and Diseases:
 
       Child Nodes:

 Sister Nodes: 
..expandAbnormal blistering of the skin (HP:0008066) help
..expandAbnormal cutaneous collagen fibril morphology (HP:0031512) help
..expandAbnormal cutaneous elastic fiber morphology (HP:0025082) help
..expandAbnormal dermoepidermal junction morphology (HP:0031538) help
..expandAbnormal elasticity of skin (HP:0010647) help
..expandAbnormal epidermal morphology (HP:0011124) help
..expandAbnormality of skin pigmentation (HP:0001000) help
..expandDry skin (HP:0000958) help
..expandElevated dermal desmosine content (HP:0025083) help
..expandGeneralized abnormality of skin (HP:0011354) help
..expandLichenification (HP:0100725) help
..expandLocalized skin lesion (HP:0011355) help
..expandOchronosis (HP:0030764) help
..expandPallor (HP:0000980) help
..expandPoikiloderma (HP:0001029) help
..expandRegional abnormality of skin (HP:0011356) help
..expandStiff skin (HP:0030053) help
..expandThickened skin (HP:0001072) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0010648HP:0010648Dermal translucency0ALDH18A1 CL E G H58329722ORPHA:90348Autosomal dominant cutis laxa89
HP:0010648HP:0010648Dermal translucency0B3GALT6 CL E G H12679217978ORPHA:536467B3GALT6-related spondylodysplastic Ehlers-Danlos syndromeHP:0040282 - Frequent38
HP:0010648HP:0010648Dermal translucency0CHD1 CL E G H11051915ORPHA:529965Intellectual disability-autism-speech apraxia-craniofacial dysmorphism syndromeHP:0040282 - Frequent2
HP:0010648HP:0010648Dermal translucency0COL1A1 CL E G H12772197OMIM:619115COMBINED OSTEOGENESIS IMPERFECTA AND EHLERS-DANLOS SYNDROME 1; OIEDS1373
HP:0010648HP:0010648Dermal translucency0COL1A2 CL E G H12782198OMIM:619120COMBINED OSTEOGENESIS IMPERFECTA AND EHLERS-DANLOS SYNDROME 2; OIEDS2243
HP:0010648HP:0010648Dermal translucency0COL3A1 CL E G H12812201OMIM:130050Ehlers-Danlos syndrome, Vascular type749
HP:0010648HP:0010648Dermal translucency0COL3A1 CL E G H12812201OMIM:618343Polymicrogyria with or without vascular-type ehlers-danlos syndrome749
HP:0010648HP:0010648Dermal translucency0COL3A1 CL E G H12812201ORPHA:286Vascular Ehlers-Danlos syndromeHP:0040281 - Very frequent749
HP:0010648HP:0010648Dermal translucency0COL5A1 CL E G H12892209OMIM:619329FIBROMUSCULAR DYSPLASIA, MULTIFOCAL; FMDMF660
HP:0010648HP:0010648Dermal translucency0ELN CL E G H20063327ORPHA:90348Autosomal dominant cutis laxa172
HP:0010648HP:0010648Dermal translucency0FBLN5 CL E G H105163602ORPHA:90348Autosomal dominant cutis laxa63
HP:0010648HP:0010648Dermal translucency0FOCAD CL E G H5491423377OMIM:6199913
HP:0010648HP:0010648Dermal translucency0IARS1 CL E G H33765330ORPHA:541423Growth delay-intellectual disability-hepatopathy syndromeHP:0040283 - Occasional
HP:0010648HP:0010648Dermal translucency0LMNA CL E G H40006636ORPHA:1662Restrictive dermopathyHP:0040281 - Very frequent645
HP:0010648HP:0010648Dermal translucency0POLR3A CL E G H1112830074ORPHA:3455Wiedemann-Rautenstrauch syndromeHP:0040282 - Frequent138
HP:0010648HP:0010648Dermal translucency0PPP1CB CL E G H55009282OMIM:617506Noonan syndrome-like disorder with loose anagen hair 29
HP:0010648HP:0010648Dermal translucency0PYCR1 CL E G H58319721OMIM:614438Cutis laxa, autosomal recessive, type IIIB.53
HP:0010648HP:0010648Dermal translucency0SLC25A24 CL E G H2995720662OMIM:612289Fontaine progeroid syndrome
HP:0010648HP:0010648Dermal translucency0SMAD3 CL E G H40886769OMIM:613795LOEYS-DIETZ SYNDROME 3; LDS3260
HP:0010648HP:0010648Dermal translucency0SOX18 CL E G H5434511194OMIM:137940Hypotrichosis-Lymphedema-Telangiectasia-Renal defect syndrome7
HP:0010648HP:0010648Dermal translucency0TGFBR1 CL E G H704611772OMIM:609192Loeys-Dietz syndrome 1239
HP:0010648HP:0010648Dermal translucency0TGFBR2 CL E G H704811773OMIM:610168Loeys-Dietz syndrome 2253
HP:0010648HP:0010648Dermal translucency0TWIST2 CL E G H11758120670OMIM:209885Barber-Say syndrome7
HP:0010648HP:0010648Dermal translucency0ZMPSTE24 CL E G H1026912877ORPHA:1662Restrictive dermopathyHP:0040281 - Very frequent83


Genes (22) :ALDH18A1 B3GALT6 CHD1 COL1A1 COL1A2 COL3A1 COL5A1 ELN FBLN5 FOCAD IARS1 LMNA POLR3A PPP1CB PYCR1 SLC25A24 SMAD3 SOX18 TGFBR1 TGFBR2 TWIST2 ZMPSTE24

Diseases (21) :ORPHA:90348 ORPHA:536467 ORPHA:529965 OMIM:619115 OMIM:619120 OMIM:130050 OMIM:618343 ORPHA:286 OMIM:619329 OMIM:619991 ORPHA:541423 ORPHA:1662 ORPHA:3455 OMIM:617506 OMIM:614438 OMIM:612289 OMIM:613795 OMIM:137940 OMIM:609192 OMIM:610168 OMIM:209885
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.